FDA Approves Rheumatoid Arthritis Knockoff
U.S. regulators cleared for sale a knockoff version of Johnson & Johnson’s Remicade anti-inflammatory drug, the second entry in a fledgling U.S. market for lower-cost copies of pricey biotechnology drugs.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Arthritis | Biotechnology | Health | Pharmaceuticals | Remicade | Rheumatoid Arthritis | Rheumatology